How to solve in-building connectivity issues
Solve in-building wireless challenges without the long timelines.Wilson Connectivity’s Hybrid DAS combines proven amplifier technology with fibre-optic reach, enabling rapid deployment for buildings from 100k to 500k sq ft.
The results:
Building bridges at the Oxford Med-Tech Fair: EFEC’s UK–China life sciences vision
EFEC is laying the foundations of a UK–China Life Sciences Innovation Hub to connect innovators, investors and UK partners.
Guardtech support staff member’s epic trek for cancer charity close to the business’ heart
The Haverhill cleanroom construction specialists donated £500 to Sarcoma UK to support their IT & Systems Manager Elliott Sheppard’s 25km trek in honour of his daughter Isobel
Reimagining COPD care for 450 million people: A global mission at scale
A global epidemic
Miebach Consulting doubles footprint on Abingdon Science Park
Bespoke facilities within The Science Quadrant offer additional capacity as part of ongoing growth
Universal drug target potential in scaffolding cells found across the body
Scientists have mapped underappreciated scaffolding cells in skin, known as fibroblasts. They show for the first time how fibroblasts go ‘rogue’ in many different diseases affecting multiple organs – from acne and psoriasis, to rheumatoid arthritis and inflammatory bowel disease.
Co-development agreement with US insulin pump device company for AT278 and sale of royalty and technology access fees for up to $11 million
This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR").
Invent: Life Sciences podcast - make way for advanced therapies – why manufacturing could be coming to a hospital near you
Season 3, Episode 6. In our last episode, we explored the manufacturing strategies that will be key to scaling advanced therapies. Now, we turn our focus to the UK, where new regulatory frameworks and regional collaboration are changing how therapies reach patients.
Beyond the inhaler: Why the future of COPD care is digital, continuous, and predictive
Inhalers: life-saving, but not enough
Daiichi Sankyo joins Milner Therapeutics Consortium
Daiichi Sankyo has joined the Milner Therapeutics Consortium as our tenth pharma partner.
Wilson Connectivity’s Hybrid DAS
Corporate campuses, schools, and hospitals can’t wait years for wireless coverage. With Wilson Connectivity’s Hybrid DAS, reliable service is live in weeks.
Quantum computing and AI: Synergy or deep tech rivalry?
In this article, IDTechEx explores the fascinating relationship between quantum computing and AI: two supposed tech revolutions that frequently grab the spotlight. Underneath the hype, there exist both technical synergies and competing market forces.
SynGenSys introduces NK.SET synthetic promoter library to advance natural killer cell therapies
First commercially available NK (natural killer) cell-specific promoter library enables precise and controllable gene expressionPortfolio of synthetic promoters validates SynGenSys’ platform for engineering targeted, tissue-specific gene regulation control elements
Atelerix signs agreement with CliniSciences to broaden access to cryo-free preservation solutions across Europe and North Africa
Agreement with specialist life science and diagnostic labs distributor expands global operational reach and market penetrationNew distribution channels to improve access to Atelerix’s non-cryogenic cell preservation solutions and strengthen local technical support
A leading hospital charity thanks its Daily Mirror Pride of Britain Regional Fundraiser of the Year nominee – saying they "couldn’t be prouder”
This year's Daily Mirror Pride of Britain Awards will be televised live on ITV next month. Prior to all the finalists getting through, they go through a process where regional news teams select a fundraiser from the 17 regions across the UK. For the second year running, a fundraiser from hospital charity Addenbrooke's Charitable Trust was nominated for ITV Anglia's Regional Fundraiser of the…
The smartphone revolution in lung health: Foundations for the future
Spirometry: A century-old tool in need of reinvention
TRIMTECH Therapeutics named as one of Fierce Biotech’s ‘Fierce 15’ for 2025
Fierce 15 highlights pre-commercial biotech companies driving the next generation of therapies for patients worldwide
Invent: Life Sciences podcast - Automation, Access, and the Future of Manufacturing
Manufacturing can make or break the future of cell and gene therapy. In this episode, Stuart sits down with two expert guests to share how smart design, automation, and closed systems are helping to lower costs, reduce complexity, and make therapies more accessible.
Abselion introduces Protein G Total Antibody Quantification Kit
New kit enables rapid, accurate titre measurement across broad range of IgG subclasses and species on Amperia platform
25 Years of Guardtech – a new era for cleanroom furniture & equipment fit-outs with Guardware
Suffolk-based cleanroom construction specialists the Guardtech Group have launched a new cleanroom furniture & equipment website to take their Guardware Cleanroom Hardware brand to the next level.
Closed Loop Medicine launches first personalized GLP-1 dosing platform in U.S.
WeDosify becomes CLM’s first commercially available product – delivering data-driven, adaptive dosing recommendations to improve GLP-1 adherence.Informed by 29 studies and 15,000+ patient profiles; developed to tailor GLP-1 titration and reduce side effects.
Poor connection issues? Zinwave can help
Dropped calls. Slow downloads. Lagging business apps.Sound familiar?If your office has cellular dead zones, you're not alone, and you're not imagining the impact.Many companies are still grappling with:• Lost productivity• Frustrated employees
electronRx to launch pDx App for Remote Chronic Respiratory Disease Management
Technology detects digital biomarkers to help monitor lung function and optimise therapeutic outcomes for patientselectronRx to showcase pDx at HLTH 2025 (19–22 Oct, Las Vegas)Cambridge, UK, 18 September 2025: electronRx, a
SKC Games Studio wins AI Innovation Category at Business Weekly Awards
SKC Games Studio, headquartered at The EpiCentre in Haverhill, has won the AI Innovation Category at the 35th Anniversary Business Weekly Awards, held at Queens’ College, in Cambridge on Tuesday 15th September 2025.
Taming the untamable: Medicilon Powers KRAS-targeted therapies
KRAS is one of the most frequently mutated oncogenes in human cancers. Once thought “undruggable,” recent scientific advances have enabled the development of therapies targeting KRAS mutations, especially G12C, G12D, and G13D.